Arvelle Therapeutics
Arvelle Therapeutics is a biopharmaceutical company with the mission of bringing innovative solution.
Arvelle Therapeutics is a company in biotechnology based in Europe, Middle East, and Africa (EMEA), founded in 2019.
Its activity falls under biotechnology; the profile below is assembled from public directory data.
The business is associated with Europe, Middle East, and Africa (EMEA).
Directory data places it at the Series_A stage.
The company reports a headcount in the c_00001_00010 range.
Total disclosed funding stands at about $221.8M.
| Sector | Biotechnology |
|---|---|
| Headquarters | Europe, Middle East, and Africa (EMEA) |
| Founded | 2019 |
| Employees | c_00001_00010 |
| Stage | series_a |
| Total funding | $221,846,724 |
Website: www.arvelletx.com
Browse related
Sign in to view the contact information we hold for Arvelle Therapeutics.
Create a free account
Create a free account